Medical Device | October 11, 2021
Kaneka Covid-19 kits detect all four variants simultaneously
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
The transaction is anticipated to close in the first quarter of 2022
This is Enzene Biosciences third biosimilar to be approved
Sputnik V is a two-dose shot and has an efficacy of 91.6% against COVID 19
Vikas Lifecare has already paid Rs. 25 million to the Advik bankers till date and the remaining amount shall also be paid within July 2021, making Advik a debt free company
This investment is being made to set up a high speed 400 vials a minute injectable fill line with isolator technology
Cadila's ZyCov-D (DNA-based vaccine) is undergoing phase III trials.
It is expected that the drug substance would be available from August 2021 which will be supplied back to Bharat Biotech for producing COVAXIN
The facility is expected to be completed in 2024
Jubilant announced the completion of demerger of pharma and LSI business into two separate companies
Subscribe To Our Newsletter & Stay Updated
